Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Metastatic Pancreatic Adenocarcinoma × PEGPH20 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Neoplasms 1 Metastatic Pancreatic Adenocarcinoma 1 Esophageal Neoplasms 1 Breast Neoplasms 1

Interventions

Gemcitabine 3 Irinotecan 2 Albumin-Bound Paclitaxel 2 ibrutinib 1 adavosertib 1 Paclitaxel 1 PEGPH20 1 Oxaliplatin 1 Leucovorin 1 Fluorouracil 1 Docetaxel 1 Cisplatin 1 Capecitabine 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01959139 2024-02-09

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

SWOG Cancer Research Network

Phase 1/2 Completed

126 enrolled 19 charts

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡